Incyte (INCY) Stock Forecast for 2024–2028. Sell or Buy Prediction
All stock predictions
All currency forecasts
All cryptocurrency predictions

This Month Predictions for INCY stock
Incyte Corp. Analysis
INCY Stock News


Popular stocks:
Suncor Energy
Tilray
QUALCOMM
Square

TOP Stocks:
Microsoft
Apple
Tesla
Alibaba
Amazon
American Airlines
NVIDIA
Adobe

Shares of other companies:
PPL
Digital World Acquisition
Xilinx
The Sherwin-Williams
Cyngn
IMAC Holdings
Baozun
Post Holdings Partnering
Generac Holdings
Alpine 4 Holdings


Financial News

Popular Stocks Analysis

Helpful Highlights
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
  1. Home
    2. »
  2. Stock forecasts
    3. »
  3. INCY

Incyte (INCY) Stock Forecast for 2024–2028. Sell or Buy?

Updated: May 4, 2024 (14:47)

Sector: Healthcare

The share price of Incyte Corp. (INCY) now

Latest session on the 3rd of May for
Incyte Corp. is positive
Trading Volume: 1407391
Open: 53.7 /  High: 53.87 /  Low: 52.73
What analysts predict: $72.41
52-week High/Low: $67.36 / $50.27

50/200 Day Moving Average: $56.31 / $58.99

This figure corresponds to the Average Price over the previous 50/200 days. For Incyte stocks, the 50-day moving average is the resistance level today.

For Incyte stocks, the 200-day moving average is the resistance level today.

Are you interested in Incyte Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Incyte stock price in 2024, 2025, 2026, 2027, 2028. How much will one Incyte share be worth in 2024 - 2028?

When should I take profit in Incyte stock? When should I record a loss on Incyte stock? What are analysts' forecasts for Incyte stock? What is the future of Incyte stock? We forecast Incyte stock performance using neural networks based on historical data on Incyte stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Incyte stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Incyte shares. This happens once a day.


Historical and forecast chart of Incyte stock

The chart below shows the historical price of Incyte stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Incyte stock price can be found in the table below.

Long-term forecasts by years.

Incyte Corp is an American pharmaceutical company. The company was founded in Palo Alto, California in 1991 and became famous in 1993. Incyte has one drug, Jakafi, which has been approved by the US Food and Drug Administration (FDA) and has been prescribed to patients in the United States.

www.incyte.com

Incyte daily forecast for a month

Date Target Pes. Opt. Vol., %
May 06 55.84 55.34 57.13 3.24
May 07 56.24 55.49 57.05 2.83
May 08 56.45 55.46 57.18 3.08
May 09 55.35 54.32 56.39 3.82
May 10 56.89 55.97 57.27 2.32
May 11 57.04 56.39 58.05 2.94
May 12 57.54 56.59 58.30 3.02
May 13 58.30 56.94 59.28 4.12
May 14 57.74 56.53 58.55 3.59
May 15 57.50 56.48 58.10 2.87
May 16 55.79 54.47 56.63 3.96
May 17 55.69 55.32 56.73 2.54
May 18 55.37 54.19 55.70 2.79
May 19 56.12 54.91 56.86 3.56
May 20 55.45 54.45 56.66 4.06
May 21 56.84 56.16 58.14 3.52
May 22 57.61 56.57 58.32 3.09
May 23 58.75 57.57 59.23 2.88
May 24 57.32 55.98 58.01 3.62
May 25 56.14 55.26 57.03 3.20
May 26 56.05 55.50 56.51 1.82
May 27 54.86 53.97 55.22 2.32
May 28 54.46 53.81 55.53 3.19
May 29 55.38 54.86 56.28 2.57
May 30 54.95 54.19 55.80 2.98
May 31 54.75 53.65 55.18 2.85
Jun 01 55.41 54.87 56.05 2.15
Jun 02 54.08 52.94 54.79 3.49
Jun 03 53.35 52.13 54.51 4.57
Jun 04 53.57 52.28 54.81 4.83

Incyte Daily Price Targets


Incyte Stock Forecast 05-06-2024.

Forecast target price for 05-06-2024: $55.84.
Positive dynamics for Incyte shares will prevail with possible volatility of 3.137%.
Pessimistic target level: 55.34
Optimistic target level: 57.13

Incyte Stock Forecast 05-07-2024.

Forecast target price for 05-07-2024: $56.24.
Positive dynamics for Incyte shares will prevail with possible volatility of 2.750%.
Pessimistic target level: 55.49
Optimistic target level: 57.05

Incyte Stock Forecast 05-08-2024.

Forecast target price for 05-08-2024: $56.45.
Positive dynamics for Incyte shares will prevail with possible volatility of 2.992%.
Pessimistic target level: 55.46
Optimistic target level: 57.18

Incyte Stock Forecast 05-09-2024.

Forecast target price for 05-09-2024: $55.35.
Negative dynamics for Incyte shares will prevail with possible volatility of 3.680%.
Pessimistic target level: 54.32
Optimistic target level: 56.39

Incyte Stock Forecast 05-10-2024.

Forecast target price for 05-10-2024: $56.89.
Positive dynamics for Incyte shares will prevail with possible volatility of 2.265%.
Pessimistic target level: 55.97
Optimistic target level: 57.27

Incyte Stock Forecast 05-11-2024.

Forecast target price for 05-11-2024: $57.04.
Positive dynamics for Incyte shares will prevail with possible volatility of 2.859%.
Pessimistic target level: 56.39
Optimistic target level: 58.05

INCY (INCY) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jun. 53.62 50.87 56.03 9.22
Jul. 53.33 50.49 54.67 7.64
Aug. 54.67 52.26 57.03 8.37
Sep. 50.68 49.45 53.01 6.71
Oct. 46.58 44.11 49.51 10.92
Nov. 45.87 42.85 47.89 10.52
Dec. 46.44 43.18 48.53 11.02
Full forecast for 2024

Incyte forecast for this year


Incyte Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $53.6156. Pessimistic: $50.87. Optimistic: $56.03


Incyte Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $53.3261. Pessimistic: $50.49. Optimistic: $54.67


Incyte Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $54.6699. Pessimistic: $52.26. Optimistic: $57.03


Incyte Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $50.6844. Pessimistic: $49.45. Optimistic: $53.01


Incyte Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $46.579. Pessimistic: $44.11. Optimistic: $49.51


Incyte Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $45.8663. Pessimistic: $42.85. Optimistic: $47.89


Incyte Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $46.4443. Pessimistic: $43.18. Optimistic: $48.53



Incyte (INCY) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 44.56 42.64 46.05 7.40
Feb 45.33 42.18 47.41 11.01
Mar 44.47 43.15 45.79 5.77
Apr 42.23 40.21 44.36 9.34
May 38.50 36.91 40.06 7.87
Jun 38.81 37.45 39.62 5.47
Jul 40.84 39.52 42.38 6.76
Aug 43.52 41.60 46.46 10.45
Sep 45.56 42.36 47.78 11.33
Oct 48.39 46.95 51.70 9.18
Nov 49.13 46.21 52.31 11.66
Dec 52.09 51.16 54.86 6.75
Full forecast for 2025

Incyte (INCY) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 50.87 47.44 52.80 10.15
Feb 49.64 47.54 52.01 8.59
Mar 50.93 48.32 54.33 11.05
Apr 50.61 48.88 52.39 6.69
May 55.03 53.00 58.85 9.93
Jun 59.34 56.19 63.19 11.07
Jul 59.66 58.53 62.02 5.63
Aug 59.93 55.88 61.33 8.88
Sep 55.67 52.31 58.47 10.54
Oct 51.61 49.75 54.16 8.15
Nov 50.77 48.08 54.11 11.15
Dec 48.67 47.36 49.85 5.01
Full forecast for 2026

Incyte (INCY) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 50.69 48.59 52.28 7.07
Feb 52.01 50.09 55.33 9.47
Mar 52.95 50.52 55.14 8.38
Apr 51.99 49.14 53.30 7.81
May 52.60 49.52 55.44 10.67
Jun 57.05 55.20 60.03 8.04
Jul 58.44 54.86 61.01 10.09
Aug 61.44 59.89 65.36 8.37
Sep 60.39 57.94 61.69 6.08
Oct 58.65 57.27 62.76 8.75
Nov 57.38 54.54 59.14 7.77
Dec 57.79 53.63 58.83 8.84
Full forecast for 2027

Incyte (INCY) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 62.79 59.23 64.99 8.87
Feb 61.99 59.65 66.07 9.71
Mar 63.89 61.65 66.88 7.82
Apr 65.16 62.11 67.91 8.55
May 66.21 63.05 69.85 9.73
Jun 68.12 65.79 70.45 6.61
Jul 71.61 68.71 74.51 7.78
Aug 68.71 65.68 70.01 6.18
Sep 69.58 68.08 74.40 8.50
Oct 68.33 66.54 72.45 8.15
Nov 68.33 66.30 70.11 5.44
Dec 70.54 66.67 74.98 11.09
Full forecast for 2028

Incyte information and performance

Incyte Address

1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, US

Market Capitalization: 11 920 882 000 $

Market capitalization of the Incyte Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of INCY shares in the company outstanding by the market price of one share.

EBITDA: 801 760 000 $

EBITDA of Incyte is earnings before interest, income tax and depreciation of assets.

PE Ratio: 16.09

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 0.695

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 3.3

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 6.71
Quarterly Revenue Growth YOY: 0.089
Trailing PE: 16.09

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 11.39

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.294

Enterprise Value (EV) /Revenue

EV To EBITDA: 9.22

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 224541000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector

ACADIA Pharmaceuticals Inc. (ACAD)
Becton Dickinson and Company (BDX)
Aadi Bioscience, Inc. (AADI)
Haemonetics Corporation (HAE)
Novo Nordisk A/S (NVO)
Aridis Pharmaceuticals, Inc. (ARDS)
Absci Corporation (ABSI)
Pacific Biosciences of California, Inc. (PACB)
Cassava Sciences, Inc. (SAVA)
DexCom, Inc. (DXCM)


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.


This website uses cookies to ensure you get the best experience on our website